ENTITY

SciSparc (SPRC US)

83
Analysis
Health Care • Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
•15 Mar 2024 10:24•Broker

Keep a Close Watch on the FTSE Rebalancing

The SET Index is expected to weaken, with the support at 1,388/1,380 points (50-day EMA/10-day EMA) and the resistance at 1,400/1,405 points. As...

Logo
91 Views
Share
bullish•Ichitan
•28 Nov 2023 10:52•Broker

Today's Dominant Ideas

Technically, the SET Index is expected to move sideways up, with the resistance at 1,405/1,412 points (10-day and 25-day EMA) and the support at...

Logo
86 Views
Share
bearish•SciSparc
•10 Oct 2023 10:14•Broker

Krungthai XSpring Technical Eng. October 10, 2023

Asian bourses closed mixed within a narrow range, with the Middle East crisis boosting energy stocks, especially PTTEP, amid market concerns about...

Logo
87 Views
Share
•18 Sep 2023 10:30•Broker

Today's Dominant Ideas

Technically, the SET Index is expected to move up, with the resistance at 1,550/1,555 points and the support at 1,537/1,529 points (the gap opened...

Logo
82 Views
Share
bullish•Thai Oil
•07 Sep 2023 16:32•Broker

Thai Oil: Strong Earnings Outlook; CFP to Boost New Normal Earnings Base

We re-initiate TOP with a Buy rating. Our valuation metrics suggest that the share price is now undervalued, while the long-term earnings growth...

Logo
93 Views
Share
x